| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | See Remarks | President And CEO +1 more
2 companies
Hughes Thomas E. is a See Remarks at Larimar Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 3 buys and 5 sells.
Estimated insider holdings value: $721K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 11, 2018 | VRDN Viridian Therapeutics, Inc.\de | Director | Buy | 10,000 | $4.77 | $47,697.00 | +353.7% | |
| Jun 28, 2018 | LRMR Larimar Therapeutics, Inc. | See Remarks | Sell | 32,000 | $10.00 | $320,000.00 | -20.4% | |
| Mar 7, 2018 | LRMR Larimar Therapeutics, Inc. | See Remarks | Sell | 5,000 | $10.00 | $50,000.00 | -3.1% | |
| Dec 20, 2017 | VRDN Viridian Therapeutics, Inc.\de | Director | Sell | 12,000 | $8.00 | $96,000.00 | -80.9% | |
| Aug 29, 2016 | LRMR Larimar Therapeutics, Inc. | President And CEO | Buy | 10,000 | $3.00 | $29,987.00 | +18.5% | |
| Jul 22, 2016 | LRMR Larimar Therapeutics, Inc. | President And CEO | Buy | 5,000 | $3.02 | $15,104.00 | +10.2% | |
| Sep 18, 2015 | LRMR Larimar Therapeutics, Inc. | Chief Executive Officer | Sale+OE | 45,626 | $42.53 | $1,940,670.00 | -96.5% |